MCF-7 breast cancer cells expressing ABCB1 as a resistance mechanism have been observed to exhibit higher glycolytic metabolism than their parental counterparts, reducing their selective fitness50, and it is probable that the ABCG2 expression observed in K562 DasR intermediates imposed a similar fitness cost. The gene discussed is ABCG2; the disease is breast carcinoma.